Guardant Health Director Vests RSUs, Acquires 154 Shares
Guardant Health, Inc.
Subscribe to track GH
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Guardant Health Director Vests RSUs
Company: Guardant Health, Inc. (GH) Form: 4 | Filed: 2025-11-03 Significance: Low
Insider: Krognes Steve E. Title: null | Relationship: Director
Transaction: • Type: RSU Vesting • Shares: 154 • Price: $0.00 • Value: $0 • Owned After: 18,436
Key Insight: A director acquired a small number of shares through the routine vesting of a previously granted restricted stock unit award.
Market Context: The transaction is non-discretionary and has no market value, representing a negligible 0.00012% of the company's outstanding shares.
Comprehensive Analysis
SEC Filing Analysis: Guardant Health, Inc. (GH)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director acquired 154 shares of common stock through the routine vesting of a Restricted Stock Unit (RSU) award, a non-market transaction with no cash value.
- Market Impact: Neutral. This is a pre-scheduled event and does not reflect new insider sentiment.
Company Information
| Field | Value |
|---|---|
| Company | Guardant Health, Inc. |
| Ticker Symbol | GH |
| CIK | 0001576280 |
| Industry | SERVICES-MEDICAL LABORATORIES |
Insider Information
| Field | Value |
|---|---|
| Name | Krognes Steve E. |
| CIK | 0001666236 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-31 |
| Transaction Code | M (Exercise/Conversion of derivative security) |
| Security Type | Common Stock |
| Shares Involved | 154 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 18,436 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.00% |
| Shares Transacted | 154 |
| % of Shares Outstanding | 0.00012% |
| Post-Transaction Ownership | 18,436 shares (0.015% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The transaction has a $0 value and is immaterial against the company's $11.72 billion market capitalization.
- Ownership Concentration: The director's post-transaction ownership of 0.015% is not a significant concentration of shares.
- Dilution Impact: The vesting of 154 shares represents a negligible 0.00012% of shares outstanding and has no meaningful dilutive effect on existing shareholders.
- Transaction Significance: The transaction is a routine, non-discretionary vesting of RSUs and carries no new market signal or investment thesis.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a non-market, pre-planned transaction with zero cash value, indicating no change in insider sentiment or new information.
Volume & Sentiment
- Expected Volume Impact: None. The transaction is a transfer of equity as compensation, not an open market trade.
- Sentiment Indicator: Neutral. The event is a routine part of an executive compensation plan.
Additional Context
Transaction Notes
- Special Circumstances: The transaction represents the vesting of a portion of an RSU award granted on August 9, 2022. This is a scheduled event, not a discretionary trade.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
